
GSK vs ORMP
$GSK vs $ORMP head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
GSK vs ORMP: trend, levels and the market
One year to 2026-11-20, against the S&P 500 (+5.7%). Split-adjusted daily closes.
- ·Both are in downtrends, below their 50- and 200-day averages, so neither has turned up yet.
- ·Only ORMP beat the market over the past year, by 41.8%, while GSK trailed the S&P 500 at +5.7% by 2.1%.
- ·The last month has flipped the order: GSK has held up better over the month (-6.7% against -13.3%) even though ORMP leads over the year.
- ·ORMP has support 9.7% below at $3.22; GSK has no tested support within 35% under its price.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
GSK vs ORMP: the quick read
- ·GSK is the larger company by market cap ($96.73B vs $160M).
- ·GSK has been more active on our scanner (80 vs 26 alerts in 30 days).
- ·ORMP has the smaller float (34.8M vs 2.00B), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·They trade in different worlds by share price: ORMP is a low-priced stock where a few cents is a real percentage move, while the other is priced for steadier increments.
- ·GSK draws far more of our scanner's attention, 80 unusual-volume alerts in 30 days against 26, so it is the more actively traded of the two by some distance.
- ·They are not really peers by size: GSK is more than 603x the market cap of ORMP, so the same dollar of news moves ORMP far harder.
- ·GSK pays a dividend and ORMP does not, which usually means one is being held for income and the other for the move.
- ·ORMP is the one in play today, trading about 2.1x its normal volume, which is what puts a name on our scanner in the first place.
Objective differences only. Not investment advice.
Watching GSK or ORMP? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing GSK and ORMP on TheDesperateTrader.
- Is GSK or ORMP the better stock?
- "Better" depends on your goal, and these two are not alike. GSK is the larger company by market cap ($96.73B vs $160M). GSK has been more active on our scanner (80 vs 26 alerts in 30 days). ORMP has the smaller float (34.8M vs 2.00B), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between GSK and ORMP?
- The differences that matter: GSK is roughly 603x the size of the other by market cap ($96.73B vs $160M); they trade at very different share prices ($47.70 vs $3.57); GSK sits at 12% of its 52-week range against 38% for ORMP; only GSK pays a dividend; our scanner flagged GSK 80 times in the last 30 days against 26 for ORMP. Everything above is measured from the latest completed session and SEC filings.
- Which of GSK and ORMP is more active right now?
- Right now GSK is at about 0.7x its normal volume and ORMP is at about 2.1x, so ORMP is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is GSK or ORMP in the stronger trend?
- GSK is below its 50-day average of $49.31 and below its 200-day average of $52.25; ORMP is below its 50-day average of $4.25 and below its 200-day average of $4.07. They split the head-to-head evenly, 2 measures each (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading GSK or ORMP? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.